Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic Surgical Patients
Launched by SENGKANG GENERAL HOSPITAL · Apr 19, 2022
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. between 40-90 years old
- • 2. are sarcopenia (defined by the Asian Workgroup of Sarcopenia 2019 definition)
- • 3. due to undergo elective major gastrointestinal surgery
- • 4. able to satisfy at least 2 weeks of prehabilitation before surgery
- • 5. ambulant
- • 6. able to comply with physiotherapy and dietician advice
- Exclusion Criteria:
- • 1. Are pregnant
- • 2. Are prisoners
- • 3. Intellectually, mentally or emotionally deemed not able to provide an informed consent and/or are unable to fill up the post-procedure questionnaires
- • 4. Have disease conditions requiring emergent/semi-emergent operation
- • 5. Diabetes on oral hyperglycemic agents (OHGA)
- • 6. Chronic Kidney Disease (CKD) or End-stage Renal Failure (ESRF)
- • 7. Unable to or decline assessment for sarcopenia
About Sengkang General Hospital
Sengkang General Hospital (SKGH) is a leading healthcare institution in Singapore, dedicated to providing comprehensive medical services and advancing clinical research to enhance patient care. As a key player in the region's healthcare landscape, SKGH is committed to fostering innovation through clinical trials that explore new therapies and treatments. The hospital is equipped with state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals, ensuring a robust environment for conducting high-quality research. By prioritizing ethical standards and patient safety, Sengkang General Hospital aims to contribute significantly to the global medical community and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Frederick H Koh, FRCSEd
Principal Investigator
Sengkang General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials